- Home
- ARRY vs APLT Comparison
ARRY vs APLT Comparison
Compare ARRY & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARRY
- APLT
- Stock Information
- Founded
- ARRY 1989
- APLT 2016
- Country
- ARRY United States
- APLT United States
- Employees
- ARRY N/A
- APLT N/A
- Industry
- ARRY Semiconductors
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- ARRY Technology
- APLT Health Care
- Exchange
- ARRY Nasdaq
- APLT Nasdaq
- Market Cap
- ARRY 785.6M
- APLT 44.0M
- IPO Year
- ARRY 2020
- APLT 2019
- Fundamental
- Price
- ARRY $7.47
- APLT $0.41
- Analyst Decision
- ARRY Buy
- APLT Buy
- Analyst Count
- ARRY 20
- APLT 7
- Target Price
- ARRY $9.47
- APLT $6.10
- AVG Volume (30 Days)
- ARRY 10.9M
- APLT 2.6M
- Earning Date
- ARRY 08-07-2025
- APLT 08-06-2025
- Dividend Yield
- ARRY N/A
- APLT N/A
- EPS Growth
- ARRY N/A
- APLT N/A
- EPS
- ARRY N/A
- APLT N/A
- Revenue
- ARRY $1,064,767,000.00
- APLT $265,000.00
- Revenue This Year
- ARRY $24.15
- APLT $1,768.13
- Revenue Next Year
- ARRY $13.19
- APLT $292.85
- P/E Ratio
- ARRY N/A
- APLT N/A
- Revenue Growth
- ARRY N/A
- APLT N/A
- 52 Week Low
- ARRY $3.76
- APLT $0.30
- 52 Week High
- ARRY $12.06
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- ARRY 54.13
- APLT 58.87
- Support Level
- ARRY $7.22
- APLT $0.32
- Resistance Level
- ARRY $7.92
- APLT $0.36
- Average True Range (ATR)
- ARRY 0.50
- APLT 0.04
- MACD
- ARRY 0.06
- APLT 0.01
- Stochastic Oscillator
- ARRY 77.49
- APLT 94.92
About ARRY Array Technologies Inc.
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.